Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers, Exosomes & Liquid Biopsy Asia 2019

Jan Lötvall's Biography



Jan Lötvall, Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

Jan Lötvall, MD PhD, is Professor at the Institute of Medicine at Göteborg University since 2002 where he directs a research laboratory studying extracellular vesicles. He is a medical specialist in both Clinical Allergy and Clinical Pharmacology, and has a long-term experience in translational studies in in primarily inflammatory models, but also cancer. JLs laboratory was first to show that exosomes carry and shuttle RNA between cell, published in 2007. He was first elected President of the International Society of Extracellular Vesicles (ISEV, 2011-2016), and has recently taken over the editor in chief position for the society’s Journal of Extracellular Vesicles (JEV, IF 11.00). During the period of May 2016 to January 2018, JL served as Chief Scientist at Codiak BioSciences, a startup biotech company focusing on developing exosomes as a therapeutic platform. In 2018, JL spent a sabbatical at Massachusetts General Hospital, working with Professor Xandra Breakefield (Harvard). JL has multiple patents for the use of extracellular vesicles as diagnostic or therapeutic tools.

Jan Lötvall Image

Emerging Applications of Extracellular Vesicles in Medicine

Monday, 9 September 2019 at 09:00

Add to Calendar ▼2019-09-09 09:00:002019-09-09 10:00:00Europe/LondonEmerging Applications of Extracellular Vesicles in MedicineCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul, KoreaSELECTBIOenquiries@selectbiosciences.com

Extracellular vesicles (EVs) are released by all cells in the human body, and can reflect the status and function of the releasing cell. Further, EVs can shuttle cargo molecules from one cell to another, including proteins and RNA. The human body is exceptionally rich in EVs, and it has over the last ten years been acknowledge that the phenotype of these vesicles change in disease, and that EVs indeed can be utilized for diagnostic purposes, for example in cancer. Further, the functionality of EVs can in multiple ways be harnessed for the development of future biological medications. This presentation will discuss the diversity of EVs isolated from human tissues, and will also touch upon the opportunities of developing EVs as powerful therapeutics.


Add to Calendar ▼2019-09-09 00:00:002019-09-10 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019Circulating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul, KoreaSELECTBIOenquiries@selectbiosciences.com